Related Experiment Video
Updated: Dec 20, 2025

08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.9K
Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle
1Department of Cell Biology, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
Trends in Cancer
|May 28, 2020
Summary
Immune cells release exosomes, tiny vesicles carrying molecules that influence immunity and cancer. These exosomes show potential for cancer diagnosis, immunotherapy, and drug delivery.
Area of Science:
- Cell biology
- Immunology
- Cancer research
Background:
- Cells communicate via extracellular vesicles (EVs).
- Exosomes, a type of EV (30-150 nm), transfer molecules like RNA and proteins between cells.
- Immune cells secrete and uptake exosomes, influencing biological processes.
Purpose of the Study:
- To explore the role of immune cell-derived exosomes in biological communication.
- To investigate the mechanisms regulating exosome biogenesis, secretion, and uptake in immune cells.
- To assess the potential applications of immune cell-derived exosomes in cancer and immunotherapy.
Main Methods:
- Literature review on exosome biogenesis, secretion, and uptake.
- Analysis of immune cell-derived exosome functions in immunity and cancer.
- Evaluation of exosome-based therapeutic and diagnostic strategies.
Main Results:
- Immune cell-derived exosomes mediate crosstalk between innate and adaptive immunity.
- These exosomes play a role in regulating cancer progression and metastasis.
- Exosomes exhibit dichotomous effects on tumor cells, potentially inducing suppressive or active immune responses.
Conclusions:
- Immune cell-derived exosomes are key mediators of intercellular communication.
- Their dual role in cancer necessitates further investigation for therapeutic targeting.
- Exosomes hold promise for cancer diagnosis, immunotherapy, vaccination, and drug delivery.
Related Concept Videos
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Regulation of Hematopoietic Stem Cells
3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

